Ronald Bordens

2.3k total citations
22 papers, 1.8k citations indexed

About

Ronald Bordens is a scholar working on Radiology, Nuclear Medicine and Imaging, Immunology and Oncology. According to data from OpenAlex, Ronald Bordens has authored 22 papers receiving a total of 1.8k indexed citations (citations by other indexed papers that have themselves been cited), including 9 papers in Radiology, Nuclear Medicine and Imaging, 9 papers in Immunology and 8 papers in Oncology. Recurrent topics in Ronald Bordens's work include Monoclonal and Polyclonal Antibodies Research (8 papers), Cytokine Signaling Pathways and Interactions (8 papers) and interferon and immune responses (7 papers). Ronald Bordens is often cited by papers focused on Monoclonal and Polyclonal Antibodies Research (8 papers), Cytokine Signaling Pathways and Interactions (8 papers) and interferon and immune responses (7 papers). Ronald Bordens collaborates with scholars based in United States, United Kingdom and Switzerland. Ronald Bordens's co-authors include Michael J. Grace, Diana Brassard, Stephen K. Youngster, James Bausch, Daniel F. Wyss, Paul P. Trotta, Ernest C. Borden, Ronald B. Herberman, Mark R. Walter and Lawrence M. Pfeffer and has published in prestigious journals such as Journal of Biological Chemistry, Advanced Drug Delivery Reviews and Journal of Hepatology.

In The Last Decade

Ronald Bordens

22 papers receiving 1.7k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Ronald Bordens United States 16 689 605 500 372 342 22 1.8k
Vincent R. Zurawski United States 28 677 1.0× 1.0k 1.7× 537 1.1× 90 0.2× 291 0.9× 44 3.2k
Diana Brassard United States 13 350 0.5× 382 0.6× 321 0.6× 188 0.5× 189 0.6× 17 1.1k
Bernardetta Nardelli United States 23 1.8k 2.6× 671 1.1× 500 1.0× 106 0.3× 261 0.8× 41 2.8k
Janice M. Davis United States 21 397 0.6× 639 1.1× 452 0.9× 90 0.2× 96 0.3× 41 1.9k
Yajun Guo China 34 1.2k 1.8× 1.2k 1.9× 1.1k 2.1× 78 0.2× 229 0.7× 95 3.1k
Éric Robinet France 23 582 0.8× 323 0.5× 427 0.9× 149 0.4× 318 0.9× 76 1.5k
Jerald J. Killion United States 25 450 0.7× 1.5k 2.5× 1.2k 2.4× 105 0.3× 111 0.3× 68 3.1k
Tao Dao United States 28 1.8k 2.6× 1.2k 2.0× 1.3k 2.6× 128 0.3× 233 0.7× 77 3.1k
Uyen Phan United States 14 679 1.0× 426 0.7× 135 0.3× 195 0.5× 276 0.8× 25 1.5k
Caroline Aspord France 25 1.7k 2.4× 493 0.8× 855 1.7× 196 0.5× 302 0.9× 63 2.4k

Countries citing papers authored by Ronald Bordens

Since Specialization
Citations

This map shows the geographic impact of Ronald Bordens's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Ronald Bordens with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Ronald Bordens more than expected).

Fields of papers citing papers by Ronald Bordens

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Ronald Bordens. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Ronald Bordens. The network helps show where Ronald Bordens may publish in the future.

Co-authorship network of co-authors of Ronald Bordens

This figure shows the co-authorship network connecting the top 25 collaborators of Ronald Bordens. A scholar is included among the top collaborators of Ronald Bordens based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Ronald Bordens. Ronald Bordens is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Silva, Marcelo, Jorge Luis Poo, Frank Wagner, et al.. (2006). A randomised trial to compare the pharmacokinetic, pharmacodynamic, and antiviral effects of peginterferon alfa-2b and peginterferon alfa-2a in patients with chronic hepatitis C (COMPARE). Journal of Hepatology. 45(2). 204–213. 87 indexed citations
2.
Halperin, Rebecca F., et al.. (2005). Use of an Automated Image Processing Program to Quantify Recombinant Adenovirus Particles. Microscopy and Microanalysis. 11(1). 37–41. 8 indexed citations
3.
Grace, Michael J., Sheri Bradshaw, Stuart Cox, et al.. (2005). Site of Pegylation and Polyethylene Glycol Molecule Size Attenuate Interferon-α Antiviral and Antiproliferative Activities through the JAK/STAT Signaling Pathway. Journal of Biological Chemistry. 280(8). 6327–6336. 72 indexed citations
4.
Grace, Michael J., David L. Cutler, & Ronald Bordens. (2005). Pegylated IFNs for chronic hepatitis C: an update. Expert Opinion on Drug Delivery. 2(2). 219–226. 17 indexed citations
5.
Brassard, Diana, Stuart Cox, Douglas W. Leaman, et al.. (2004). Regulation of Gene Expression by Pegylated IFN- α 2b and IFN- α 2b in Human Peripheral Blood Mononuclear Cells. Journal of Interferon & Cytokine Research. 24(8). 455–469. 10 indexed citations
6.
Youngster, Stephen K., et al.. (2002). Structural and biological characterization of pegylated recombinant interferon alpha-2b and its therapeutic implications. Advanced Drug Delivery Reviews. 54(4). 547–570. 313 indexed citations
7.
Youngster, Stephen K., et al.. (2002). Structure, Biology, and Therapeutic Implications of Pegylated Interferon Alpha-2b. Current Pharmaceutical Design. 8(24). 2139–2157. 67 indexed citations
8.
Luxon, Bruce A., Michael J. Grace, Diana Brassard, & Ronald Bordens. (2002). Pegylated interferons for the treatment of chronic hepatitis C infection. Clinical Therapeutics. 24(9). 1363–1383. 93 indexed citations
9.
Yang, Tong‐Yuan, et al.. (2002). The Use of Field Emission Scanning Electron Microscopy to Assess Recombinant Adenovirus Stability. Human Gene Therapy. 13(14). 1687–1696. 16 indexed citations
10.
Brassard, Diana, Michael J. Grace, & Ronald Bordens. (2002). Interferon-α as an immunotherapeutic protein. Journal of Leukocyte Biology. 71(4). 565–581. 191 indexed citations
11.
Grace, Michael J., Stephen K. Youngster, Gerry Gitlin, et al.. (2001). Structural and Biologic Characterization of Pegylated Recombinant IFN- α 2b. Journal of Interferon & Cytokine Research. 21(12). 1103–1115. 137 indexed citations
12.
Zhu, Jingdong, et al.. (1999). Characterization of Replication-Competent Adenovirus Isolates from Large-Scale Production of a Recombinant Adenoviral Vector. Human Gene Therapy. 10(1). 113–121. 70 indexed citations
13.
Swanson, Steven J., et al.. (1999). Applications for the new electrochemiluminescent (ECL) and biosensor technologies.. PubMed. 97. 135–47. 21 indexed citations
14.
Walter, Mark R., Ronald Bordens, Tattanahalli L. Nagabhushan, et al.. (1998). Review of Recent Developments in the Molecular Characterization of Recombinant Alfa Interferons on the 40th Anniversary of the Discovery of Interferon. Cancer Biotherapy and Radiopharmaceuticals. 13(3). 143–154. 29 indexed citations
15.
Pfeffer, Lawrence M., Charles A. Dinarello, Ronald B. Herberman, et al.. (1998). Biological properties of recombinant alpha-interferons: 40th anniversary of the discovery of interferons.. PubMed. 58(12). 2489–99. 400 indexed citations
16.
17.
Jacobs, Sheila, et al.. (1997). A highly sensitive electrochemiluminescence immunoassay for interferon alfa-2b in human serum. Journal of Immunological Methods. 206(1-2). 25–33. 28 indexed citations
18.
Bordens, Ronald, et al.. (1980). Microencapsulated antibodies in radioimmunoassay. III. Determination of cortisol.. Clinical Chemistry. 26(5). 633–634. 3 indexed citations
19.
Bordens, Ronald, et al.. (1979). Microencapsulated antibodies in radioimmunoassay. II. Determination of free thyroxine.. Clinical Chemistry. 25(9). 1561–1563. 9 indexed citations
20.
Bordens, Ronald, et al.. (1979). Microencapsulated antibodies in radioimmunoassay--I. Determination of digoxin.. Clinical Chemistry. 25(6). 860–862. 4 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Vincent R. Zurawski Breakdown of academic impact, for papers by Diana Brassard Breakdown of academic impact, for papers by Bernardetta Nardelli Breakdown of academic impact, for papers by Janice M. Davis Breakdown of academic impact, for papers by Yajun Guo Breakdown of academic impact, for papers by Éric Robinet Breakdown of academic impact, for papers by Jerald J. Killion Breakdown of academic impact, for papers by Tao Dao Breakdown of academic impact, for papers by Uyen Phan Breakdown of academic impact, for papers by Caroline Aspord
Rankless by CCL
2026